During a 6-week period, 10 patients were admitted to a hospital for treatment of knee or shoulder joint infections due to Serratia species. Isolates from eight patients were identified as Serratia marcescens with identical biochemical characteristics and antibiotic susceptibility patterns. Before the onset of infections, all patients had been treated by two orthopedic surgeons who shared an office. Studies revealed that infections were associated with previous joint injections (P = 4.44 x 10-5) of methylprednisolone and lidocaine.
Septic arthritis due to Serratia species is rare, with fewer than 50 cases having been reported in the literature (3, 5, 19) ; no epidemics of these infections have been reported. However, nosocomial epidemics of infections at other sites as a result of Serratia species have been traced to multiple sources including contaminated solutions and disinfectants, intravenous fluids, arterial-pressure monitors, mechanical respirators, intermittent positive-pressure breathing machines, intravenous catheters, ultrasonic nebulizers, fiberoptic bronchoscopes, and hand-to-hand transmission by hospital personnel (9, 25) .
When septic arthritis due to Serratia marcescens was diagnosed in 10 patients admitted to a community hospital, intrinsic contamination of a product used for joint injections in the office of three orthopedic physicians was suspected. However, because the product was widely distributed and the reports of these infections were localized to only one geographic location, we believed that this was an unlikely source of the outbreak. We report here the results of the outbreak investigation, which identified contaminated aqueous benzalkonium chloride as a possible source.
MATERIALS AND METHODS
Epidemiologic investigation. A case was initially defined as the occurrence of joint fluid that was culture positive for Serratia species in a patient. To To assess potential risk factors for developing joint infections, we performed two case-control studies. For the first study, 35 control patients were selected at random from an appointment log of all 265 patients who visited the physicians' office from 6 to 14 January 1982. Office medical records of cases and controls were reviewed for the following information: appointment time, whetherjoint injection(s) was given at the visit, and medications used for injection. For the second study, all 42 patients who had received joint injections or aspirations during the period 6 to 14 January, but who did not become infected, were selected as control patients. In this study, the following predisposing risk factors were examined: diagnosis, previous surgery on the involved joint, and the number of previous injections to the involved joint, excluding the injection received during the period 6 to 14 January. We interviewed the two orthopedic surgeons who had injected the patients who later developed septic arthritis and the two office nurses for information on techniques used for joint injections and general office practices.
Laboratory studies. The hospital microbiology laboratory identified patient isolates by using standard biochemical procedures and the API system (Analytab Products, Plainview, N.Y.) (14, 23 oratories) from a partially used container, benzalkonium chloride-soaked cotton balls obtained from two canisters in the office, and a 50-ml vial of lidocaine (Xylocaine 1%; Astra Pharmaceutical Products, Inc.) which had been partially used.
Since intrinsic contamination of multiple-dose vials of methylprednisolone (Depo-Medrol; The Upjohn Co.) was initially suspected by one of the physicians, three 10-ml vials (lot numbers 014JH and 609JP) had been sampled in the office by nurse B on January 14, three (lot number 014JH) had been sampled on January 15, and three (lot number 014JH) had been sampled on January 18, and the samples had been sent to the hospital microbiology laboratory for culture. The exact technique used to acquire the samples could not be determined. All nine vials with remaining contents were also sent to CDC for culture. Twenty unopened vials of Depo-Medrol (lot number 014JH) were obtained from The Upjohn Co. and were also cultured at CDC. At CDC, all isolates were identified by standard biochemical tests (7). Bauer-Kirby antimicrobial susceptibility testing (2) and serotyping (7) were also completed.
Twenty-six unopened vials of Depo-Medrol (lot number 014JH) were returned to The Upjohn Co. from the doctors' office and were cultured at The Upjohn Co. laboratory. The Food and Drug Administration cultured three unopened Depo-Medrol vials (lot number 014JH) obtained from the doctors' office. Six patients were men, and five were women. Their mean age was 57.8 years (range, 34 to 76 years). Of the 10 hospitalized patients, 8 had fever above 37.8°C. Four had peripheral leukocyte counts greater than 10,000/mm3. Joint fluid cell counts were available for five patients, and these ranged from 33,524 to 158,572/mm3. All hospitalized patients required prolonged therapy with intravenous antibiotics; six patients received surgical drainage of infected joints, five patients received intra-articular antibiotics, and surgical intervention was being considered for several other patients. At the time the investigation was concluded, most hospitalized patients were still undergoing therapy in the hospital. Figure 2 shows the cases of Serratia joint infections by date of the last joint injection. Isolates from two patients whose last joint injection was in December 1981 were characterized as a Serratia sp. with the same antibiotic susceptibility pattern: resistant to ampicillin, cephalothin, colistin, and tetracycline; susceptible to carbenicillin, chloramphenicol, gentamicin, kanamycin, tobramycin, and cefamandole. This pattern differed slightly from that of isolates from patients whose last joint injection was in January 1982.
RESULTS
Isolates from these patients were characterized as S. marcescens with the following antibiotic susceptibility pattern: resistant to cephalothin, colistin, and tetracycline; susceptible to ampicillin, carbenicillin, chloramphenicol, gentamicin, kanamycin, tobramycin, and cefamandole. On the basis of antibiotic susceptibility testing and lack of definitive speciation, the two patients whose last injection was in December 1981 were thought to possibly represent a separate cluster and were excluded from further studies. Additionally, the one patient who had a single joint culture positive for S. marcescens in November but whose symptoms had resolved within 24 h without specific therapy was also excluded from subsequent studies, since it was unclear whether he represented a definite case. Thus, for the purpose of case-control studies, a case was redefined as the occurrence ofjoint fluid culture positive for S. marcescens in a patient who had received his last joint injection in January The typical joint injection by surgeon A required the use of one needle and two syringes, one containing Xylocaine and the other containing Depo-Medrol. The skin was prepped, and the Xylocaine syringe was used to enter the joint space and to inject the local anesthetic. While the needle remained in the joint space, the empty Xylocaine syringe was removed and replaced with the Depo-Medrol syringe. Approximately 1 mI of Depo-Medrol was then injected into the joint space. No gloves were worn, and no additional hand preparation was done.
On 30 January, to test the hypothesis that an environmental office contaminant could have been introduced into a sterile multiple-dose vial, we asked nurse B to withdraw a small sample of broth from a vial of commercial culture medium (tryptic soy broth) by the same technique she would have used when filling syringes before mid-December. This vial was similar to the multiple-dose Depo-Medrol and Xylocaine vials in that it had to be entered by puncturing the rubber diaphragm on the top with a needle. Nurse B used a Zephiran-soaked cotton ball from the canister in the utility room to disinfect the vial diaphragm before withdrawing the sample. The vial with remaining contents was sent to CDC for culture.
Microbiology results. Of the samples sent to CDC, the following were positive for S. marcescens: subcultures of joint fluid isolates from four patients who had had their last injection in January 1982; two vials of Depo-Medrol, from two different lot numbers (014JH and 609JP), which had been sampled by nurse B in the office on 14 January; and samples from the canister of Zephiran-soaked cotton balls'in the utility room. Quantitative counts of S. marcescens in the Depo-Medrol vials were 2.1 x 105 and 1.7 x 105 CFU/ml. Fluid expressed from the Zephiran-soaked cotton balls contained 2.3 x 106 CFU/ml. All patient and environmental isolates had identical biochemical characteristics, antibiotic susceptibility patterns, and serotype (05:H-undetermined).
The vial of culture media sampled by nurse B was also positive for the same strain of S. marcescens.
Reports confirmed by telephone communication indicated that the 26 unopened vials of Depo-Medrol (lot number 014JH) cultured by The Upjohn Co. and the 3 vials cultured by the Food and Drug Administration were sterile. The 20 unopened vials of Depo-Medrol (lot number 014JH) received by CDC from The Upjohn Co. were cultured and found to be sterile.
DISCUSSION
The results of our investigation reveaIed that 10 patients developed joint infections with Serratia spp. in two clusters: one cluster of 2 patients with Serratia sp. infections in December 1981, and one cluster of 8 patients with S. marcescens infections in January 1982. Of the several possible mechanisms for the pathogenesis of septic arthritis, the most important in the present study appeared to be the introduction of organisms into the joint space at the time of intra-articular injection. This could have occurred if one or more of the following were contaminated: medication(s) used to inject the joint, instruments used to inject the joint, skin overlying the site of injection, or the hands of personnel performing the procedure. (1, 3, 5, 6, 11, 15, 16, 18, (20) (21) (22) 24) . Additionally, instances of septic arthritis associated with intra-articular steroid injections have been reported (10, 12, 20) .
Intrinsic and extrinsic contamination of aqueous quaternary ammonium compounds such as Zephiran has been well documented previously and has been the subject of concern for many years (4) . Contamination is usually due to gramnegative organisms and has resulted in a number of nosocomial outbreaks, including outbreaks due to Serratia spp. (4, 8, 9) . Cotton and other materials have been shown to inactivate aqueous quaternary ammonium compounds after prolonged contact with them (13) . We found it interesting that the preservative in the Depo-Medrol product used during this outbreak, -y-myristyl picolinium chloride, is also an aqueous quaternary ammonium compound. Laboratory studies determined that the strain of S. marcescens recovered in this outbreak was relatively resistant to Zephiran as well as to the preservative in Depo-Medrol (17) .
Since the removal of Zephiran as an antiseptic and disinfectant from the physicians' office, no further cases of arthritis due to S. marcescens have been reported.
